Whole Genome Bi-Sulfite Sequencing files for RMS.
WGBS files accompanying the paper titled "Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses".
- 37 samples
- DAC: EGAC00001000044
- Technology: Illumina HiSeq 2000
DAC to obtain datasets submitted by St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project
This document refers to a data set, which has been submitted to the European Genome Archive (EGA) for the restricted access by legitimate academic institutions that have agreed to comply with the terms of a Data Access Agreement drafted by the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project Steering Committee. There are a number of steps that a researcher must take to obtain access to this data and the process is overseen by our Data Access Committee, called the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project Steering Committee. For an overview of the guidelines and information concerning data access, such as general principles, application procedure, and assessment criteria, please visit http://explore.pediatriccancergenomeproject.org/dataAccess/GuidelinesAndInformation.pdf. For the data access agreement or an application, please visit http://explore.pediatriccancergenomeproject.org/dataAccess/ApplicationForm.pdf. For all other inquiries, please email PCGP_data_request@stjude.org. We can confirm that this submission is consistent with the informed consent of the participants of the study or has been granted ethical approval and is in accordance with the applicable laws and regulations.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |